| | Title | Authors / Editors | Date |
|
unige:152634 |
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries |
Courvoisier, Delphine; Chatzidionysiou, Katarina; Mongin, Denis; Lauper, Kim; ... Finckh, Axel |
2021 |
|
unige:159906 |
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: Time trends in baseline characteristics, treatment retention and response |
Christiansen, Sara Nysom; Ørnbjerg, Lykke Midtbøll; Horskjær Rasmussen, Simon; Loft, Anne Gitte; ... Hetland, Merete L |
2021 |
|
unige:157913 |
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities |
Kvien, Tore K; Balsa, Alejandro; Betteridge, Neil; Buch, Maya H; ... Dougados, Maxime |
2020 |
|
unige:135495 |
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. |
Brahe, Cecilie Heegaard; Ørnbjerg, Lykke Midtbøll; Jacobsson, Lennart; Nissen, Michaël; ... Hetland, Merete Lund |
2019 |
|
unige:135501 |
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration |
Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Askling, Johan; Ciurea, Adrian; ... Østergaard, Mikkel |
2019 |
|
unige:128224 |
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? |
Mongin, Denis; Lauper, Kim; Turesson, Carl; Hetland, Merete Lund; ... Courvoisier, Delphine |
2019 |
|
unige:128225 |
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis |
Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K; ... Gabay, Cem |
2019 |
|
unige:128226 |
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution |
Lauper, Kim; Mongin, Denis; Alpizar Rodriguez, Deshire; Codreanu, Catalin; ... Courvoisier, Delphine |
2019 |
|
unige:111916 |
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration |
Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; ... Gabay, Cem |
2018 |
|
unige:127635 |
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries |
Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Klami Kristianslund, Eirik; ... Gabay, Cem |
2018 |
|
unige:110656 |
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L; ... van Vollenhoven, Ronald |
2017 |
|
unige:110908 |
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) |
Iannone, Florenzo; Courvoisier, Delphine S; Gottenberg, Jacques Eric; Hernandez, Maria Victoria; ... Finckh, Axel |
2017 |
|
unige:99458 |
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F |
2016 |
|
unige:86816 |
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis |
Walker, Ulrich A; Jaeger, Veronika K; Chatzidionysiou, Katerina; Hetland, Merete L; ... Gabay, Cem |
2016 |
|
unige:88670 |
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study |
Gabay, Cem; Riek, Myriam; Hetland, Merete Lund; Hauge, Ellen-Margrethe; ... Kvien, Tore K |
2016 |
|
unige:84218 |
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO |
Pavelka, Karel; Bruyère, Olivier; Cooper, Cyrus; Kanis, John A.; ... Reginster, Jean-Yves |
2016 |
|
unige:45809 |
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions |
Smolen, Josef S; Schoels, Monika M; Nishimoto, Norihiro; Breedveld, Ferdinand C; ... van der Heijde, Désirée |
2013 |
|
unige:46003 |
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial |
Gabay, Cem; Emery, Paul; van Vollenhoven, Ronald; Dikranian, Ara; ... Kavanaugh, Arthur |
2013 |
|
unige:32495 |
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem |
2012 |
|
unige:25468 |
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F |
2011 |
Pavelka, Karel
add all
remove all
